QuidelOrtho Corp (QDEL)

Industry Medical Devices

This stock can be held in an Investment ISA and an Investment Account

Sell

$15.06

Buy

$17.79

arrow-up$0.15 (+0.91%)

Prices updated at 01 Apr 2026, 12:00 EDT

Prices minimum 15 mins delay

Prices in USD

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It includes applications in infectious diseases, women's health, gastrointestinal diseases, and others.

NASDAQ

1.16%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Devices

Chairman

Dr. Kenneth F. Buechler, PhD

CEO

Mr. Brian J. Blaser

Most recent earnings

31 Dec 2025

Fiscal year end

31 Dec 2025

Employees

6,500

Head office

9975 Summers Ridge Road

San Diego

United States

92121

+1 858 552-1100

ruben.argueta@quidel.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Joseph M. Busky Chief Financial Officer and Principal Accounting Officer	0.59m
Dr. Matthew W. Strobeck, PhD Independent Director	0.07m
Mr. Nathaniel B. Sisitsky, Esq. Chief Legal Officer	-
Ms. Evelyn S. Dilsaver Independent Director	0.07m
Mr. Edward L. Michael Independent Director	0.09m
Dr. Kenneth F. Buechler, PhD Chairman of the Board	0.16m
Dr. Mary Lake Polan, M.D.,PhD Independent Director	0.07m
Mr. Scott Huennekens Independent Director	-
Mr. John R. Chiminski Independent Director	-
Mr. Brian J. Blaser Director, President and Chief Executive Officer	0.63m
Dr. Kenneth J. Widder, M.D. Independent Director	0.09m
Mr. Joseph D. Wilkins, Jr Independent Director	0.07m
Ms. Ann D. Rhoads Independent Director	0.10m
Mr. Ronald Lee Bowman Chief Human Resources Officer	-
Mr. Jonathan Philip Siegrist Executive Vice President, Research and Development and Chief Technology Officer	0.12m
Mr. Philip D. McLellan Chief Operations Officer	0.41m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
T. Rowe Price Investment Management,Inc.	16,770,804
BlackRock Inc	10,220,156
Vanguard Group Inc	7,572,075
T. Rowe Price	7,451,643
BlackRock Fund Advisors	7,421,177

Director dealings

Date chevron-l-regular chevron-r-regular	Action
10 Dec 2025	-
26 Nov 2025	-
25 Nov 2025	-
25 Nov 2025	-
25 Nov 2025	-
24 Nov 2025	-
21 Nov 2025	-
19 Nov 2025	-
18 Nov 2025	-
18 Nov 2025	-
18 Nov 2025	-
15 Oct 2025	-
15 Oct 2025	-
15 Oct 2025	-
15 Oct 2025	-
15 Oct 2025	-
15 Oct 2025	-
15 Sep 2025	-
15 Sep 2025	-
15 Sep 2025	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.